Lifetime Liquid D3 Targets Vitamin D Deficiencies in U.S. Population
Baywood International, Inc. (OTCBB:BAYW) (“Company”) announced that three of the largest testing labs in the United States, Quest Diagnostics, Lab Corp. of America and the Mayo Clinic, have all reported a sharp rise in vitamin D testing in response to growing public and physician awareness of vitamin D deficiencies among the U.S. population. As many as 36% of all Americans lack vitamin D, according to data from the National Center for Health Statistics.
Research is growing regarding the numerous health problems associated with vitamin D deficiencies, including an increased risk of heart attack in men and lower survival rates for women with breast cancer. Orders for vitamin D testing jumped 80% from May 2007 to May 2008 at Quest Diagnostics in Madison, New Jersey and 90% at Burlington, North Carolina-based Lab Corp. of America from 2007 to 2008. Testing orders have also been rising at the Mayo Clinic in Rochester, Minnesota, which expects to process more than half a million vitamin D tests by the end of this year. Supplementation is a key to preventing vitamin D deficiencies, and many doctors now recommend adults take 1,000 IUs daily.
LifeTime’s Liquid D3 provides vitamin D3 (cholecalciferol) in an easy-to-take, once-daily dose. Vitamin D3 is the preferred form, due to its high level of biologic activity. The main function of vitamin D is to maintain normal blood levels of calcium and phosphorus. It also aids in the absorption of calcium, helping to form and maintain strong bones. Without vitamin D, bones can become thin, brittle, soft, or misshapen. In addition, without vitamin D, the small intestine absorbs no more than 10-15% of dietary calcium. In a person with vitamin D sufficiency, the small intestine absorbs, on average, 30% of dietary calcium; during growth, lactation, and pregnancy, the efficiency increases to 80%. By the time a person reaches adulthood, bone growth stops and bone remodeling continues. Vitamin D deficiency in adults causes secondary hyperparathyroidism that can precipitate and exacerbate osteoporosis.
Vitamin D3 is the preferable form of vitamin D (as opposed to vitamin D2, ergocalciferol) due to its higher potency and longer duration of action. Vitamin D2 potency is less than one third that of vitamin D3. LifeTime Liquid D3 contains 1,000 IU per serving, or 250% of the USRDA, of Vitamin D3 (Cholecalciferol) and was designed to address the deficiency of Vitamin D consumption. The product is available in mixed berry in a 16 fluid ounce size, providing 32, once-daily servings. For more information, visit http://www.lifetimevitamins.com/products/lifetime_lqd3.html.
Baywood International, Inc. (OTCBB:BAYW) (“Baywood”) is a nutritional science company that develops, markets and sells nutraceutical and nutritionally enhanced products and new age beverages under its own brands. Baywood merges its expertise in nutritional formulation with its leverage in sales and distribution to deliver the most effective and progressive products to market. Currently, Baywood’s products are sold under three brands that are distributed into retail markets nationwide and internationally as follows:
— LifeTime(R) – Available in independent and chain health food stores, natural grocery stores, and other direct-to-consumer channels both internationally and domestically (www.lifetimevitamins.com)
— Baywood PURECHOICE(R), Baywood SOLUTIONS(R) and Complete La Femme(R) – Available in independent and chain health food stores, natural grocery stores, and other direct-to-consumer channels both internationally and domestically (www.bywd.com)
— Mamajuana Extreme(TM) – Available in select convenience stores and chain stores nationwide (www.mamajuanaextreme.com)
(a) Source: USA Today, NBJ
This press release may contain forward-looking statements, made in reliance upon Section 21D of the Exchange Act of 1934, which involve known and unknown risks, uncertainties or other factors that could cause actual results to differ materially from the results, performance, or expectations implied by these forward-looking statements. The Company’s expectations, among other things, are dependent upon general economic conditions, continued demand for its products, the availability of raw materials, retention of its key management and operating personnel, its ability to integrate the business of Lifetime, need for and availability of additional capital as well as other uncontrollable or unknown factors which are more fully disclosed in the Company’s Form 10-Ks and 10-Qs on file with the United States Securities and Exchange Commission.